The number of adults over 55 years with atrial fibrillation (AF) is expected to continue growing at a significant rate. Grow your knowledge of AF and learn about Vericiguat, an emerging class of drug treating heart failure in this MEDD webinar.
We value your privacy
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By using MEDD, you consent to our use of cookies. To find out more about the cookies we use, please see our Privacy Policy